Results 201 to 210 of about 257,105 (351)

Assessment of Double Outlet Left Ventricle in Pediatrics Using Transthoracic Echocardiography and Computed Tomographic Angiography

open access: yesPediatric Discovery, EarlyView.
The clinical manifestation of DOLV was atypical. TTE has a relatively high diagnostic accuracy for DOLV in pediatric, which is very valuable for its early detection. ABSTRACT Double outlet left ventricle (DOLV) is a rare congenital cardiac anomaly in which both great arteries originate entirely or predominantly from the morphologic left ventricle.
Xu Zhu   +6 more
wiley   +1 more source

MAGNESIUM SUPPLEMENTATION IN THE PREVENTION OF ARRHYTHMIAS IN PEDIATRIC PATIENTS UNDERGOING SURGERY FOR CONGENITAL HEART DEFECTS

open access: bronze, 1999
B. Hugh Dorman   +8 more
openalex   +1 more source

Chronic hypoxia: A model for cyanotic congenital heart defects [PDF]

open access: bronze, 2002
Antonio F. Corno   +4 more
openalex   +1 more source

Clinical and genetic characteristics of Cornelia de Lange syndrome in pediatric patients

open access: yesPediatric Investigation, EarlyView.
NIPBL variants (78.9%) dominate 19 Chinese pediatric Cornelia de Lange syndrome (CdLS). Universal craniofacial anomalies (94.7%) and developmental delay (84.2%) were observed. NIPBL null variants are associated with severe growth impairment and microcephaly, yet overall clinical severity remains heterogeneous, underscoring genotype‐phenotype complexity
Xiaoqiao Li   +10 more
wiley   +1 more source

Development of Heart Failure and Congenital Septal Defects in Mice Lacking Endothelial Nitric Oxide Synthase [PDF]

open access: bronze, 2002
Qingping Feng   +6 more
openalex   +1 more source

ALK2 mutation in a patient with Down's syndrome and a congenital heart defect

open access: yesEuropean Journal of Human Genetics, 2011
I. Joziasse   +12 more
semanticscholar   +1 more source

Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape

open access: yesSmall, EarlyView.
This review presents a detailed overview of clinically approved nanoparticle therapeutics, classifying them by type and discussing their unique advantages in drug delivery. It highlights regulatory challenges across global markets and emphasizes the need for adaptive approval pathways.
Nimeet Desai   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy